Isoray - Innovative Brachytherapy

Our favorite prostate cancer support resources: 2018 edition

Roughly the same number of American men will be diagnosed with prostate cancer (1 in 9) as women will be diagnosed with breast cancer (1 in 8) every year. However, for a variety of reasons, prostate cancer awareness does not employ the same level of awareness breast cancer does. In efforts to raise awareness around prostate cancer, we hope you will find useful, and more importantly share, our favorite prostate cancer patient resources 2018 edition.

It is of paramount importance for men to take an active role in their own treatment course to achieve the optimum quality of life post-treatment.

Prostate cancer is highly treatable and there are multiple organizations whose mission is to help educate as well as provide support to men and their families dealing with a prostate cancer diagnosis. The list of resources available is extensive. Here are just a few of Isoray’s recommended patient advocacy groups and organizations.

The Prostate Cancer Free Foundation
The Prostate Cancer Free Foundation works to help people interested in, and affected by prostate cancer through education and research. The Foundation is supported by the members of the Prostate Cancer Results Study Group. The Prostate Cancer Results Study Group evaluates and compares the effectiveness and long term results of various prostate cancer treatments.

Our colleague and Cesium-131 user for prostate brachytherapy Dr. Alex Hsi is a Prostate Cancer Free Foundation board member.

They find studies, analyze outcomes, and present the data in a clear, digestible way so that men better understand and can make informed decisions regarding their treatment. The graph is updated regularly and provided to a large network of patients and physicians around the world.  

To take a look at the latest iteration of the chart click here.


Contact / 206.453.2987

The Prostate Cancer Research Institute

Best left said in their own words: “The Prostate Cancer Research Institute’s mission is to improve the quality of prostate cancer patients and caregivers’ lives by supporting research and disseminating information that educates and empowers patients, families, and the medical community.

“The Prostate Cancer Research Institute (PCRI), a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for you. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call us at 1 (800) 641-7274 with any question that you have.”

You are not alone

Take a look at some of our interviews with a few of the more than 12,000 prostate cancer survivors who chose brachytherapy with Cesium-131 as their treatment modality.

Our “Blu” community puts patients first by delivering highly targeted treatment to the tumor, with limited dose to the surrounding tissue and a reduction in total radiation time compared to other options.



The Merger: Paving the Way for Tomorrow

The Merger: Paving the Way for Tomorrow

By CEO Lori Woods We began this journey with a simple truth. Standing still is never an option. And the history of Isoray underscores that reality. When Isoray was founded, we were focused on the treatment of prostate cancer utilizing Cesium-131. Some saw it as a...

read more
It’s the Details That Make Cesium-131 The Better Choice

It’s the Details That Make Cesium-131 The Better Choice

By Peter T. Heiberger, M.S. DABR, RSOLead Medical Physicist, Radiation Oncology, Aurora Health Care, Green Bay, WI When I think about Cesium-131 an old expression comes to mind. “It's the little details that are vital. Little things make big things happen.” When it...

read more
Lessons Learned About Cesium-131

Lessons Learned About Cesium-131

By Brian J. Moran, M.D. FABSMedical Director, Prostate Cancer Foundation of Chicago I am a radiation oncologist who, like many of you, has always looked for opportunities to do more for those I treat. That is how I first learned about Cesium-131 brachytherapy. In the...

read more